BeautyHealth Stock Receives Mixed Analyst Outlook Amid Recent Gains
Published on 09/23/2025 at 07:18 | Redaktion boerse-global.deBeauty Health Co shares are trading slightly higher in early market activity, buoyed by fresh commentary from financial analysts. While the overall sentiment remains cautious, some firms are pointing to potential recovery signs for the specialty aesthetics company.
Expressing notable confidence, Roth Capital commenced coverage of Beauty Health on Friday with a Buy recommendation. Analyst George Kelly set a price target of $3.50, citing the company’s successful management restructuring and financial estimates he views as overly conservative. The firm anticipates that cost-saving initiatives and new product launches scheduled for late 2025 and 2026 will provide significant momentum.
TD Cowen Maintains Caution Despite Target Increase
In a contrasting move, TD Cowen adjusted its valuation on Tuesday, raising the... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
